Bringing Tradition Back at Drexel s 2021 Commencement | Now drexel.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from drexel.edu Daily Mail and Mail on Sunday newspapers.
From left are Mark McNash, Senior Vice President Support Services at Tower Health, Nick Fazzini, Project Manager at L.F. Driscoll, and Karen Restifo, MD, JD, Dean of the Drexel University College of Medicine. During a tour of the Drexel University College of Medicine at Tower Health under construction in Wyomissing Tuesday afternoon May 4, 2021.
BEN HASTY â READING EAGLE
BEN HASTY â READING EAGLE
BEN HASTY â READING EAGLE
BEN HASTY â READING EAGLE
BEN HASTY â READING EAGLE
Thursday, 13 May 2021 07:47 AM MYT
The CDC said in a presentation the agency has now identified 28 cases of thrombosis with thrombocytopenia syndrome (TTS) among the more than 8.7 million people who had received the J&J vaccine. Reuters pic
Subscribe to our Telegram channel for the latest updates on news you need to know.
CHICAGO, May 13 ― The US Centers for Disease Control and Prevention said yesterday it had found more cases of potentially life-threatening blood clotting among people who received the Johnson & Johnson Covid-19 vaccine and sees a “plausible causal association.”
The CDC said in a presentation the agency has now identified 28 cases of thrombosis with thrombocytopenia syndrome (TTS) among the more than 8.7 million people who had received the J&J vaccine. TTS involves blood clots accompanied by a low level of platelets ― the cells in the blood that help it to clot.
May 13, 2021
An international leader in RNA biology, Drew Weissman, MD, PhD, a professor of medicine at the Perelman School of Medicine at the University of Pennsylvania, will address the graduates of Drexel’s College of Medicine during its commencement ceremony on May 18.
Research by Weissman and researcher Katalin Karikó, PhD, laid the groundwork for the mRNA vaccines for COVID-19 developed by Pfizer/BioNTech and Moderna. Using the approaches developed by Weissman and Karikó enabled the development and authorization of the Pfizer/BioNTech and Moderna vaccines within nine months; and both vaccines have shown efficacy rates around 95%. Thus far, over 250 million doses of one of these mRNA- based COVID vaccines have been administered in the United States.